Ablation Technique

A Minnesota-based medical technology company announced a limited commercial launch of its OneRF Ablation System, which creates radiofrequency lesions in nervous tissue for functional neurosurgical procedures.

The FDA has granted 510(k) clearance for marketing of an ablation system that creates radiofrequency lesions in nervous tissue for functional neurosurgical procedures, according to the manufacturer.

CathVision announced the FDA clearance and commercial availability of two algorithms as part of its artificial intelligence-powered EP recording system for ECG interpretation.

Biosense Webster announced the U.S. launch of a catheter to help electrophysiologists with mapping complex cardiac arrhythmias.

With more than 20 million procedures performed to date in the U.S., LASIK is still the most popular and most performed laser vision correction method, according to the Refractive Surgery Council.

Up to 60% of stroke survivors develop cognitive impairment within 1 year, which is why the American Heart Association issued a new scientific statement that cognition screenings should be part of follow-up care.

In a real-world population, pulsed field ablation using a novel catheter was safe for most patients with atrial fibrillation in routine practice, with 78% free from AF at 1 year, registry data show.

Radiofrequency ablation technique was not associated with any difference in atrial fibrillation recurrence after redo ablation despite durable initial pulmonary vein isolation, researchers reported.

Improved atrial fibrillation ablation strategies and technologies during the past decade are associated with a stepwise reduction in the rate of redo AF procedures, increased procedural volume and shortened procedure times, data show.

Stryker has announced FDA 510(k) clearance for its OptaBlate bone tumor ablation system for patients with metastatic cancer, according to a press release.